nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A4—Esomeprazole—Barrett's esophagus	0.231	0.629	CbGbCtD
Fluticasone Propionate—CYP3A4—Omeprazole—Barrett's esophagus	0.136	0.371	CbGbCtD
Fluticasone Propionate—Fracture—Esomeprazole—Barrett's esophagus	0.0128	0.0259	CcSEcCtD
Fluticasone Propionate—Multiple fractures—Omeprazole—Barrett's esophagus	0.0128	0.0259	CcSEcCtD
Fluticasone Propionate—Fracture—Omeprazole—Barrett's esophagus	0.0128	0.0259	CcSEcCtD
Fluticasone Propionate—Multiple fractures—Esomeprazole—Barrett's esophagus	0.0128	0.0259	CcSEcCtD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.0106	0.0772	CbGpPWpGaD
Fluticasone Propionate—Rash erythematous—Omeprazole—Barrett's esophagus	0.00972	0.0196	CcSEcCtD
Fluticasone Propionate—Rash erythematous—Esomeprazole—Barrett's esophagus	0.00972	0.0196	CcSEcCtD
Fluticasone Propionate—NR3C2—Preimplantation Embryo—CDX2—Barrett's esophagus	0.00963	0.07	CbGpPWpGaD
Fluticasone Propionate—Ageusia—Omeprazole—Barrett's esophagus	0.00919	0.0186	CcSEcCtD
Fluticasone Propionate—Ageusia—Esomeprazole—Barrett's esophagus	0.00919	0.0186	CcSEcCtD
Fluticasone Propionate—NR3C2—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00907	0.066	CbGpPWpGaD
Fluticasone Propionate—Eye irritation—Omeprazole—Barrett's esophagus	0.00872	0.0176	CcSEcCtD
Fluticasone Propionate—Eye irritation—Esomeprazole—Barrett's esophagus	0.00872	0.0176	CcSEcCtD
Fluticasone Propionate—Candida infection—Esomeprazole—Barrett's esophagus	0.00711	0.0144	CcSEcCtD
Fluticasone Propionate—Candida infection—Omeprazole—Barrett's esophagus	0.00711	0.0144	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00699	0.0509	CbGpPWpGaD
Fluticasone Propionate—Lightheadedness—Omeprazole—Barrett's esophagus	0.00666	0.0135	CcSEcCtD
Fluticasone Propionate—Lightheadedness—Esomeprazole—Barrett's esophagus	0.00666	0.0135	CcSEcCtD
Fluticasone Propionate—Sleep disorder—Esomeprazole—Barrett's esophagus	0.00624	0.0126	CcSEcCtD
Fluticasone Propionate—Sleep disorder—Omeprazole—Barrett's esophagus	0.00624	0.0126	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00605	0.044	CbGpPWpGaD
Fluticasone Propionate—PGR—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00553	0.0402	CbGpPWpGaD
Fluticasone Propionate—Face oedema—Esomeprazole—Barrett's esophagus	0.00522	0.0105	CcSEcCtD
Fluticasone Propionate—Face oedema—Omeprazole—Barrett's esophagus	0.00522	0.0105	CcSEcCtD
Fluticasone Propionate—Irritability—Esomeprazole—Barrett's esophagus	0.00516	0.0104	CcSEcCtD
Fluticasone Propionate—Irritability—Omeprazole—Barrett's esophagus	0.00516	0.0104	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Omeprazole—Barrett's esophagus	0.00486	0.00983	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Esomeprazole—Barrett's esophagus	0.00486	0.00983	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Omeprazole—Barrett's esophagus	0.0047	0.0095	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Esomeprazole—Barrett's esophagus	0.0047	0.0095	CcSEcCtD
Fluticasone Propionate—Asthma—Esomeprazole—Barrett's esophagus	0.00467	0.00944	CcSEcCtD
Fluticasone Propionate—Asthma—Omeprazole—Barrett's esophagus	0.00467	0.00944	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Omeprazole—Barrett's esophagus	0.00459	0.00928	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00459	0.00928	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.0044	0.032	CbGpPWpGaD
Fluticasone Propionate—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00434	0.00877	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00434	0.00877	CcSEcCtD
Fluticasone Propionate—Infestation—Esomeprazole—Barrett's esophagus	0.00416	0.00841	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00416	0.00841	CcSEcCtD
Fluticasone Propionate—Infestation—Omeprazole—Barrett's esophagus	0.00416	0.00841	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Omeprazole—Barrett's esophagus	0.00416	0.00841	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00405	0.00818	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00405	0.00818	CcSEcCtD
Fluticasone Propionate—NR3C1—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00404	0.0294	CbGpPWpGaD
Fluticasone Propionate—Epistaxis—Esomeprazole—Barrett's esophagus	0.00393	0.00794	CcSEcCtD
Fluticasone Propionate—Epistaxis—Omeprazole—Barrett's esophagus	0.00393	0.00794	CcSEcCtD
Fluticasone Propionate—Sinusitis—Esomeprazole—Barrett's esophagus	0.00391	0.00789	CcSEcCtD
Fluticasone Propionate—Sinusitis—Omeprazole—Barrett's esophagus	0.00391	0.00789	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00372	0.00752	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00372	0.00752	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Omeprazole—Barrett's esophagus	0.00371	0.0075	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00371	0.0075	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00367	0.00742	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00367	0.00742	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CRTC1—Barrett's esophagus	0.00358	0.026	CbGpPWpGaD
Fluticasone Propionate—Eye disorder—Omeprazole—Barrett's esophagus	0.00349	0.00706	CcSEcCtD
Fluticasone Propionate—Eye disorder—Esomeprazole—Barrett's esophagus	0.00349	0.00706	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00338	0.00682	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Omeprazole—Barrett's esophagus	0.00338	0.00682	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00337	0.00681	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00337	0.00681	CcSEcCtD
Fluticasone Propionate—Mental disorder—Esomeprazole—Barrett's esophagus	0.00327	0.00662	CcSEcCtD
Fluticasone Propionate—Mental disorder—Omeprazole—Barrett's esophagus	0.00327	0.00662	CcSEcCtD
Fluticasone Propionate—Malnutrition—Omeprazole—Barrett's esophagus	0.00325	0.00657	CcSEcCtD
Fluticasone Propionate—Malnutrition—Esomeprazole—Barrett's esophagus	0.00325	0.00657	CcSEcCtD
Fluticasone Propionate—NR3C1—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00319	0.0232	CbGpPWpGaD
Fluticasone Propionate—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00313	0.00632	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Omeprazole—Barrett's esophagus	0.00313	0.00632	CcSEcCtD
Fluticasone Propionate—Vision blurred—Omeprazole—Barrett's esophagus	0.00307	0.0062	CcSEcCtD
Fluticasone Propionate—Vision blurred—Esomeprazole—Barrett's esophagus	0.00307	0.0062	CcSEcCtD
Fluticasone Propionate—Tremor—Omeprazole—Barrett's esophagus	0.00305	0.00616	CcSEcCtD
Fluticasone Propionate—Tremor—Esomeprazole—Barrett's esophagus	0.00305	0.00616	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00302	0.0061	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00302	0.0061	CcSEcCtD
Fluticasone Propionate—Agitation—Esomeprazole—Barrett's esophagus	0.00299	0.00604	CcSEcCtD
Fluticasone Propionate—Agitation—Omeprazole—Barrett's esophagus	0.00299	0.00604	CcSEcCtD
Fluticasone Propionate—NR3C2—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00299	0.0217	CbGpPWpGaD
Fluticasone Propionate—Angioedema—Omeprazole—Barrett's esophagus	0.00297	0.00601	CcSEcCtD
Fluticasone Propionate—Angioedema—Esomeprazole—Barrett's esophagus	0.00297	0.00601	CcSEcCtD
Fluticasone Propionate—Malaise—Esomeprazole—Barrett's esophagus	0.00293	0.00593	CcSEcCtD
Fluticasone Propionate—Malaise—Omeprazole—Barrett's esophagus	0.00293	0.00593	CcSEcCtD
Fluticasone Propionate—Palpitations—Omeprazole—Barrett's esophagus	0.00287	0.00581	CcSEcCtD
Fluticasone Propionate—Palpitations—Esomeprazole—Barrett's esophagus	0.00287	0.00581	CcSEcCtD
Fluticasone Propionate—Cough—Omeprazole—Barrett's esophagus	0.00284	0.00574	CcSEcCtD
Fluticasone Propionate—Cough—Esomeprazole—Barrett's esophagus	0.00284	0.00574	CcSEcCtD
Fluticasone Propionate—Hypertension—Esomeprazole—Barrett's esophagus	0.00281	0.00568	CcSEcCtD
Fluticasone Propionate—Hypertension—Omeprazole—Barrett's esophagus	0.00281	0.00568	CcSEcCtD
Fluticasone Propionate—Chest pain—Omeprazole—Barrett's esophagus	0.00277	0.0056	CcSEcCtD
Fluticasone Propionate—Arthralgia—Omeprazole—Barrett's esophagus	0.00277	0.0056	CcSEcCtD
Fluticasone Propionate—Chest pain—Esomeprazole—Barrett's esophagus	0.00277	0.0056	CcSEcCtD
Fluticasone Propionate—Arthralgia—Esomeprazole—Barrett's esophagus	0.00277	0.0056	CcSEcCtD
Fluticasone Propionate—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00276	0.0201	CbGpPWpGaD
Fluticasone Propionate—Anxiety—Esomeprazole—Barrett's esophagus	0.00276	0.00558	CcSEcCtD
Fluticasone Propionate—Anxiety—Omeprazole—Barrett's esophagus	0.00276	0.00558	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00275	0.00556	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00275	0.00556	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Endothelins—SLC9A1—Barrett's esophagus	0.00275	0.02	CbGpPWpGaD
Fluticasone Propionate—Discomfort—Omeprazole—Barrett's esophagus	0.00274	0.00553	CcSEcCtD
Fluticasone Propionate—Discomfort—Esomeprazole—Barrett's esophagus	0.00274	0.00553	CcSEcCtD
Fluticasone Propionate—CYP3A7—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00273	0.0198	CbGpPWpGaD
Fluticasone Propionate—Dry mouth—Omeprazole—Barrett's esophagus	0.00271	0.00547	CcSEcCtD
Fluticasone Propionate—Dry mouth—Esomeprazole—Barrett's esophagus	0.00271	0.00547	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00266	0.00537	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00266	0.00537	CcSEcCtD
Fluticasone Propionate—Infection—Esomeprazole—Barrett's esophagus	0.00264	0.00533	CcSEcCtD
Fluticasone Propionate—Infection—Omeprazole—Barrett's esophagus	0.00264	0.00533	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Omeprazole—Barrett's esophagus	0.0026	0.00526	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.0026	0.00526	CcSEcCtD
Fluticasone Propionate—Tachycardia—Esomeprazole—Barrett's esophagus	0.00259	0.00524	CcSEcCtD
Fluticasone Propionate—Tachycardia—Omeprazole—Barrett's esophagus	0.00259	0.00524	CcSEcCtD
Fluticasone Propionate—Skin disorder—Esomeprazole—Barrett's esophagus	0.00258	0.00521	CcSEcCtD
Fluticasone Propionate—Skin disorder—Omeprazole—Barrett's esophagus	0.00258	0.00521	CcSEcCtD
Fluticasone Propionate—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00255	0.0185	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00242	0.00489	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00242	0.00489	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00237	0.00478	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Omeprazole—Barrett's esophagus	0.00237	0.00478	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear Receptors—PPARG—Barrett's esophagus	0.0023	0.0167	CbGpPWpGaD
Fluticasone Propionate—Pain—Esomeprazole—Barrett's esophagus	0.00227	0.00459	CcSEcCtD
Fluticasone Propionate—Pain—Omeprazole—Barrett's esophagus	0.00227	0.00459	CcSEcCtD
Fluticasone Propionate—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00224	0.0163	CbGpPWpGaD
Fluticasone Propionate—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00219	0.00442	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00219	0.00442	CcSEcCtD
Fluticasone Propionate—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.00218	0.0159	CbGpPWpGaD
Fluticasone Propionate—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00217	0.00439	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00217	0.00439	CcSEcCtD
Fluticasone Propionate—Urticaria—Esomeprazole—Barrett's esophagus	0.00211	0.00426	CcSEcCtD
Fluticasone Propionate—Urticaria—Omeprazole—Barrett's esophagus	0.00211	0.00426	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Esomeprazole—Barrett's esophagus	0.0021	0.00424	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Omeprazole—Barrett's esophagus	0.0021	0.00424	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Esomeprazole—Barrett's esophagus	0.0021	0.00424	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Omeprazole—Barrett's esophagus	0.0021	0.00424	CcSEcCtD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Barrett's esophagus	0.00206	0.015	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.002	0.0145	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00197	0.0143	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00196	0.00395	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00196	0.00395	CcSEcCtD
Fluticasone Propionate—Pruritus—Omeprazole—Barrett's esophagus	0.00188	0.0038	CcSEcCtD
Fluticasone Propionate—Pruritus—Esomeprazole—Barrett's esophagus	0.00188	0.0038	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00182	0.0132	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00182	0.00367	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Omeprazole—Barrett's esophagus	0.00182	0.00367	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.00179	0.013	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Omeprazole—Barrett's esophagus	0.00176	0.00355	CcSEcCtD
Fluticasone Propionate—Dizziness—Esomeprazole—Barrett's esophagus	0.00176	0.00355	CcSEcCtD
Fluticasone Propionate—Vomiting—Esomeprazole—Barrett's esophagus	0.00169	0.00341	CcSEcCtD
Fluticasone Propionate—Vomiting—Omeprazole—Barrett's esophagus	0.00169	0.00341	CcSEcCtD
Fluticasone Propionate—Rash—Omeprazole—Barrett's esophagus	0.00167	0.00338	CcSEcCtD
Fluticasone Propionate—Rash—Esomeprazole—Barrett's esophagus	0.00167	0.00338	CcSEcCtD
Fluticasone Propionate—Dermatitis—Esomeprazole—Barrett's esophagus	0.00167	0.00338	CcSEcCtD
Fluticasone Propionate—Dermatitis—Omeprazole—Barrett's esophagus	0.00167	0.00338	CcSEcCtD
Fluticasone Propionate—Headache—Omeprazole—Barrett's esophagus	0.00166	0.00336	CcSEcCtD
Fluticasone Propionate—Headache—Esomeprazole—Barrett's esophagus	0.00166	0.00336	CcSEcCtD
Fluticasone Propionate—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00162	0.0118	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—Barrett's esophagus	0.00158	0.0115	CbGpPWpGaD
Fluticasone Propionate—Nausea—Esomeprazole—Barrett's esophagus	0.00158	0.00319	CcSEcCtD
Fluticasone Propionate—Nausea—Omeprazole—Barrett's esophagus	0.00158	0.00319	CcSEcCtD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.00157	0.0114	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—CYP26A1—Barrett's esophagus	0.00151	0.011	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00146	0.0106	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00146	0.0106	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Nuclear Receptors—PPARG—Barrett's esophagus	0.00133	0.00967	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Biological oxidations—CYP26A1—Barrett's esophagus	0.00119	0.00865	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00119	0.00864	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00117	0.00853	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—BMP4—Barrett's esophagus	0.00115	0.00833	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00105	0.00765	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.00104	0.00758	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.00101	0.00738	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000978	0.00712	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000955	0.00694	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.00094	0.00684	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000928	0.00675	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000916	0.00666	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—APC—Barrett's esophagus	0.000865	0.00629	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000865	0.00629	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.00086	0.00625	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000848	0.00617	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000842	0.00612	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—NR1I2—Barrett's esophagus	0.000755	0.00549	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000753	0.00547	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.000686	0.00499	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000641	0.00467	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.000622	0.00453	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.000582	0.00423	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000552	0.00401	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.000548	0.00399	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000535	0.00389	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000516	0.00375	CbGpPWpGaD
Fluticasone Propionate—Triamcinolone—PTGS2—Barrett's esophagus	0.000505	0.436	CrCbGaD
Fluticasone Propionate—NR3C1—Adipogenesis—PPARG—Barrett's esophagus	0.000497	0.00362	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000481	0.0035	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NR1I2—Barrett's esophagus	0.00046	0.00334	CbGpPWpGaD
Fluticasone Propionate—Betamethasone—PTGS2—Barrett's esophagus	0.000413	0.357	CrCbGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000406	0.00296	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.0004	0.00291	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000394	0.00287	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—GAST—Barrett's esophagus	0.000388	0.00283	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGES—Barrett's esophagus	0.000385	0.0028	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TP53—Barrett's esophagus	0.000382	0.00278	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	0.000337	0.00245	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—HGF—Barrett's esophagus	0.000331	0.0024	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000328	0.00238	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000314	0.00228	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP26A1—Barrett's esophagus	0.000292	0.00212	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GAST—Barrett's esophagus	0.000281	0.00204	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGES—Barrett's esophagus	0.000268	0.00195	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—SST—Barrett's esophagus	0.000266	0.00194	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NR1I2—Barrett's esophagus	0.000266	0.00193	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—PPARG—Barrett's esophagus	0.000248	0.00181	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000242	0.00176	CbGpPWpGaD
Fluticasone Propionate—Dexamethasone—PTGS2—Barrett's esophagus	0.00024	0.208	CrCbGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GAST—Barrett's esophagus	0.000229	0.00167	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000216	0.00157	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—SLC9A1—Barrett's esophagus	0.00021	0.00153	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	0.000203	0.00148	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGES—Barrett's esophagus	0.000194	0.00141	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SST—Barrett's esophagus	0.000193	0.0014	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000182	0.00132	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.00017	0.00123	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SST—Barrett's esophagus	0.000157	0.00114	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PPARG—Barrett's esophagus	0.000151	0.0011	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	0.000147	0.00107	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	0.000147	0.00107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—Barrett's esophagus	0.000111	0.000807	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	0.000106	0.000771	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000104	0.000755	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APC—Barrett's esophagus	0.000102	0.000741	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARG—Barrett's esophagus	9.61e-05	0.000699	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGES—Barrett's esophagus	9.02e-05	0.000656	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARG—Barrett's esophagus	8.74e-05	0.000636	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APC—Barrett's esophagus	8.32e-05	0.000605	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RELA—Barrett's esophagus	7.96e-05	0.000579	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—Barrett's esophagus	7.56e-05	0.00055	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL8—Barrett's esophagus	7.5e-05	0.000546	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	6.84e-05	0.000497	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARG—Barrett's esophagus	6.69e-05	0.000487	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RELA—Barrett's esophagus	6.5e-05	0.000473	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL8—Barrett's esophagus	6.13e-05	0.000446	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	5.27e-05	0.000383	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	4.93e-05	0.000358	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARG—Barrett's esophagus	4.84e-05	0.000352	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—Barrett's esophagus	4.6e-05	0.000335	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	3.81e-05	0.000277	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—Barrett's esophagus	3.76e-05	0.000274	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARG—Barrett's esophagus	2.25e-05	0.000164	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.77e-05	0.000129	CbGpPWpGaD
